| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_NFATC3_0012100 | Exon-Exon | chr16:68208277-68215433 | chr16:68174374-68181530 | 197 nt | 0.4112 |
| hsa_NFATC3_0012200 | Exon-Exon | chr16:68208277-68248335 | chr16:68174374-68214432 | 245 nt | 0.4204 |
| hsa_NFATC3_0012300 | Exon-Exon | chr16:68208346-68215397 | chr16:68174443-68181494 | 92 nt | 0.3913 |
| hsa_NFATC3_0012400 | Exon-Exon | chr16:68208385-68217269 | chr16:68174482-68183366 | 216 nt | 0.4213 |
| hsa_NFATC3_0012500 | Exon-Exon | chr16:68208385-68225678 | chr16:68174482-68191775 | 89 nt | 0.4045 |
| hsa_NFATC3_0012700 | Intron-Exon-Intron | chr16:68209903-68217269 | chr16:68176000-68183366 | 127 nt | 0.4331 |
| hsa_NFATC3_0012600 | Intron-Exon | chr16:68209903-68225678 | chr16:68176000-68191775 | 250 nt | 0.4240 |
| hsa_NFATC3_0013000 | Exon-Exon | chr16:68215378-68248335 | chr16:68181475-68214432 | 160 nt | 0.4750 |
| hsa_NFATC3_0013200 | Intron-Exon | chr16:68222822-68225836 | chr16:68188919-68191933 | 250 nt | 0.3400 |
| hsa_NFATC3_0013400 | Exon-Exon | chr16:68224671-68248335 | chr16:68190768-68214432 | 110 nt | 0.4545 |
A study in human peripheral whole blood samples selected the circNFATC3 for validation but eliminated it from the final age prediction model due to barely detectable expression (Ct >37) in RT-qPCR assays [Wang et al. DOI:10.3389/fgene.2022.1031806].